Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...
Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval ...
Eswatini has become the first African country to receive lenacapavir, a twice-yearly HIV prevention injection that global ...
One quietmorning, some 35 years ago, one woman from Nakuru County got news that changedher life forever. She had gone to takean HIV test but was not prepared for the outcome. The HIV test results left ...
Bishop David Abioye has clarified a statement he made during a recent sermon, explaining that his wife was diagnosed with COVID-19, not HIV, as widely circulated on social media.The cleric, who leads ...